[1]黄冬欢　卢 帅　罗丽琼　袁冬梅 王庆高.自噬对心衰心室重构的影响及中医药干预的研究[J].大众科技,2022,24(01):53-56.
　Effect of Autophagy on Ventricular Remodeling of Heart Failure and Study of Traditional Chinese Medicine Intervention[J].Popular Science & Technology,2022,24(01):53-56.
点击复制

自噬对心衰心室重构的影响及 中医药干预的研究()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
24
期数:
2022年01
页码:
53-56
栏目:
医药与卫生
出版日期:
2022-01-20

文章信息/Info

Title:
Effect of Autophagy on Ventricular Remodeling of Heart Failure and Study of Traditional Chinese Medicine Intervention
作者:
黄冬欢1　卢 帅1　罗丽琼1　袁冬梅1 王庆高2
（1.广西中医药大学研究生学院，广西 南宁 530001； 2.广西中医药大学第一附属医院，广西 南宁 530023）
关键词:
自噬; 心力衰竭; 中医药; 心室重构
Keywords:
autophagy heart failure traditional Chinese medicine ventricular remodeling
文献标志码:
A
摘要:
心力衰竭是各种心血管疾病的终末阶段，心室重构是心力衰竭疾病进展过程最重要的环节，能否有效延缓心室重构是治疗心力衰竭的重要评估指标。越来越多的研究表明，自噬在抑制心肌肥厚、心肌纤维化、延缓心室重构发挥了重要作用。文章通过对自噬在心力衰竭疾病过程中对心脏病理性重构的影响，以及中医药对自噬调节防治心力衰竭的相关研究进行综述，以期对后续研究提供参考。
Abstract:
Heart failure is the final stage of various cardiovascular diseases. Ventricular remodeling is the most important link in the progression of heart failure. Whether it can effectively delay ventricular remodeling is an important evaluation index for the treatment of heart failure. More and more studies have shown that autophagy plays an important role in inhibiting myocardial hypertrophy, myocardial fibrosis and delaying ventricular remodeling. This paper reviews the effect of autophagy oncardiac pathological remodeling in the process of heart failure disease, and the related research of autophagy regulation in traditional Chinese medicine on the prevention and treatment of heart failuree, in order to provide reference for follow-up research.

参考文献/References:

[1]　马丽媛，吴亚哲，陈伟伟. 《中国心血管病报告2018》要点介绍[J]. 中华高血压杂志，2019，27(8): 712-716. [2] Tham Y K, Bernardo B C, Ooi J Y Y, et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets[J]. Archives of Toxicology, 2015, 89(9): 1401-1438. [3] Wu Q, Xiao Y, Yuan Y, et al. Mechanisms contributing to cardiac remodelling[J]. Clinical Science, 2017, 131(18): 2319-2345. [4] Yamaguchi O. Autophagy in the heart[J]. Circulation Journal, 2019, 83(4): 697-704. [5] Ghosh R, Pattison J S. Macroautophagy and Chaperone- mediated autophagy in heart failure: The known and the unknown[J]. Oxidative Medicine and Cellular Longevity, 2018, 2018: 8602041. [6] Li Z, Wang J, Yang X. Functions of autophagy in pathological cardiac hypertrophy[J]. International Journal of Biological Sciences, 2015, 11(6): 672-678. [7] Miyamoto, S. Autophagy and cardiac aging[J]. Cell Death and Differentiation, 2019, 26(4): 653-664. [8] Zhu Y, Pires K M P, Whitehead K J, et al. Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth[J]. PLoS One, 2013, 8(1): e54221. [9] Zhang D, Sonenberg N, Condorelli G, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice[J]. Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation, 2010, 120(8): 2805- 2816. [10] Shende P, Plaisance I, Morandi C, et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gne expression, and causes heart failure in mice[J]. Circulation, 2011, 123(10): 1073-1082. [11] Dai D, Karunadharma P P, Chiao Y A, et al. Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart[J]. Aging Cell, 2014, 13(3): 529-539. [12] Flynn J M, OLeary M N, Zambataro C A, et al. Late-life rapamycin treatment reverses age-related heart dysfunction[J]. Aging Cell, 2013, 12(5): 851-862. [13] Gao G, Chen W, Yan M, et al. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling[J]. International Journal of Molecular Medicine, 2020, 45(1): 195-209. [14] Su M, Wang J, Wang C, et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis[J]. Cell Death and Differentiation, 2015, 22(6): 986-999. [15] Xu X, Kobayashi S, Timm D, et al. Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice[J]. The FASEB Journal, 2019, 33(11): 201901206R. [16] Daskalopoulos E P, Dufeys C, Beauloye C, et al. AMPK in Cardiovascular Diseases[J]. EXS, 2016, 107: 179-201. [17] Xie S, Deng Y, Pan Y Y, et al. Chronic intermittent hypoxia induces cardiac hypertrophy by impairing autophagy through the adenosine 5-monophosphate-activated protein kinase pathway[J]. Archives of Biochemistry and Biophysics, 2016, 606: 41-52. [18] Li Y, Chen C, Yao F, et al. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1[J]. Archives of Biochemistry and Biophysics, 2014, 558: 79-86. [19] Li Y, Wang Y, Zou M, et al. AMPK blunts chronic heart failure by inhibiting autophagy[J]. Bioscience Reports, 2018, 38(4): BSR20170982. [20] Sung M M, Zordoky B N, Bujak A L, et al. AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism[J]. Cardiovascular Research, 2015, 107(2): 235-245. [21] Yuan Y, Gupta A, Wu C, et al. Characteristics, management, and outcomes of patients hospitalized for heart failure in China: The China PEACE retrospective heart failure study[J]. Journal of the American Heart Association, 2019, 8(17): e012884. [22] Tan X, Liu H, Song X, et al. Honokiol post-treatment ameliorates myocardial ischemia/ reperfusion injury by enhancing autophagic flux and reducing intracellular ROS production[J]. Chemico-Biological Interactions, 2019, 307: 82-90. [23] Luo Y, Sun Z, Hu P, et al. Effect ofaqueous extract from descurainia sophia (L.) webb ex prantl on ventricular remodeling in chronic heart failure rats[J]. Evidence- Based Complementary and Alternative Medicine, 2018, 2018: 1904081. [24] Yan X, Zhang Y, Zhang L, et al. Gallic acid suppresses cardiac hypertrophic remodeling and heart failure[J]. Molecular Nutrition and Food Research, 2019, 63(5): e1800807. [25] Chen L, Li Q, Lei L, et al. Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways[J]. Life Sciences, 2018, 209: 420-429. [26] Zhang X, Yang K, Zhang H, et al. Effect of typhaneoside on ventricular remodeling and regulation of PI3K/ Akt/mTOR pathway[J]. Herz, 2020, 45(1): 113-122. [27] Yang T, Miao Y, Zhang T, et al. Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure‐overload heart failure rat model[J]. Journal of Pharmacy and Pharmacology, 2018, 70(6): 830-838. [28] Fan C, Tang X, Ye M, et al. Qi-Li-Qiang-Xin alleviates isoproterenol-induced myocardial injury by inhibiting excessive autophagy via activating aKT/mTOR pathway[J]. Frontiers in Pharmacology, 2019, 10: 1329. [29] Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure[J]. Journal of the American College of Cardiology, 2013, 62(12): 1065-1072. [30] Cao T, Chen H, Dong Z, et al. Stachydrine protects against pressure overload-induced cardiac hypertrophy by suppressing autophagy[J]. Cellular Physiology and Biochemistry, 2017, 42(1): 103-114. [31] Wang X, Jiang Y, Zhang Q, et al. Autophagy as a novel insight into mechanism of Danqi pill against post-acute myocardial infarction heart failure[J]. Journal of Ethnopharmacology, 2021, 266: 113404. [32] Shi B, Huang Y, Ni J, et al. Qi Dan Li Xin pill improves chronic heart failure by regulating mTOR/p70S6k- mediated autophagy and inhibiting apoptosis[J]. Scientific Reports, 2020, 10(1): 6105. [33] Wang B, Yang Q, Sun Y, et al. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice[J]. Journal of Cellular and Molecular Medicine, 2014, 18(8): 1599-1611. [34] Gu X, Wang Z, Ye Z, et al. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure[J]. Genetics and Molecular Research, 2014, 13(1): 323-335. [35] Gao M, Hu F, Hu M, et al. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1- mediated autophagy[J]. Bioscience Reports, 2020, 40(11): 20200661.

相似文献/References:

[1]陆意冬,黄信顺,卢建勇,等.血尿酸水平、心力衰竭超声指数及 NT-proBNP在扩张性心肌病心力衰竭患者中的变化及应用价值[J].大众科技,2019,21(08):78.
　Changes and Application Value of Blood Uric Acid Level, Heart Failure UltrasoundIndex and NT-proBNP in Patients with Dilated Cardiomyopathy and Heart Failure[J].Popular Science & Technology,2019,21(01):78.
[2]吴凌华,康善平,刘华盛,等.中西医治疗心力衰竭伴利尿剂抵抗的研究进展[J].大众科技,2020,22(04):73.
　Research Progress of Chinese and Western Medicine Treatment of HeartFailure with Diuretic Resistance[J].Popular Science & Technology,2020,22(01):73.
[3]陆　露　黄小珊　韦　飞　匡　朋　傅为武　李成林.基于肠道菌群探讨以脾论治心力衰竭[J].大众科技,2020,22(12):70.
　Discussion on Treating Heart Failure with Spleen Based on Intestinal Flora[J].Popular Science & Technology,2020,22(01):70.

备注/Memo

备注/Memo:
【收稿日期】2021-09-29 【基金项目】广西科技厅重点研发计划（桂科AB17195054）；南宁市科技局重点研发计划（20173158-2）；广西一流学科建设项目（2018XK070）；广西高校重点学科项目（2017XK03）；广西中医药大学硕士研究生创新课题（YCXJ2021040）。 【作者简介】黄冬欢（1995－），男，广西中医药大学研究生学院在读硕士研究生，研究方向为中西医结合防治心血管疾病。 【通信作者】王庆高（1971－），男，广西中医药大学第一附属医院心血管科主任医师，博士，从事临床心血管疾病治疗及研究。
更新日期/Last Update: 2022-04-19